Integrative management of canine IBD: explore microbiome modulation, diagnostics, and evidence-based nutrition, supplements, and emerging therapies to reduce inflammation and improve long-term clinical outcomes.  

Inflammatory bowel disease (IBD) in dogs is a complex, multifactorial condition that challenges clinicians with its variable presentation, unclear etiology, and often relapsing course. Emerging research highlights the central role of immune dysregulation, microbiome imbalance, and gut–brain axis interactions in driving chronic intestinal inflammation. As a result, effective management increasingly requires an integrative approach that goes beyond symptomatic control to address underlying mechanisms. This article explores current insights into the pathophysiology, diagnosis, and comprehensive treatment of canine IBD, with a focus on combining conventional care with targeted nutritional, microbial, and adjunctive therapies. 

Increasing evidence shows that IBD results from the overly aggressive immune response of genetically susceptible people and animals to the vast number of microorganisms (bacteria, fungi, viruses, and protozoa) living in and on the gut, mouth and skin. These microorganisms normally coexist without causing harm and typically provide benefits such as aiding digestion, training the immune system, and blocking pathogens.  

The microbiome – a major player  

Amazingly, the number of genes within the microbes of the microbiome is 200 times that found in the mammalian genome. We depend on the microbiome to stay alive — it protects us against germs, breaks down foods to release their energies, and produces vitamins. The most diverse and abundant microbiome organisms reside in the gut. Among their many functions, they enhance the roles of prebiotics and probiotics, which provide different benefits within the gut.  

  • Prebiotics are non-digestible fibers that promote the growth of beneficial gut bacteria, nourish the colon, and boost immune function. Being high in fiber, they can cause bloating, gas formation and discomfort if introduced too quickly in dogs with sensitive digestion or IBD.   
  • Probiotics, on the other hand, improve protein digestion and alleviate constipation, especially in elderly individuals. 

The microbiome is a major player in all areas of health. It’s present before birth, impacting maternal-offspring health outcomes, maintains the gut-brain axis, and interacts with the immune system. It plays an important role in many diseases, such as metabolic disorders, autoimmune and motor neuron disease, autism, and cancer. Recent advances in DNA sequencing technology and computational biology have revolutionized the field of microbiomics, permitting mechanistic evaluation of the relationships between an individual and their microbial symbionts. 

 The gut-brain axis has numerous functions  

  • Regulates digestion and natural movement of food along the gut
  • Regulates cognitive and emotional functions, especially important for the elderly person or animal
  • Is activated by physiological, pathological, and emotional stress
  • Stimulates mast cells and increases inflammatory cytokines leading to leaky gut and IBD
  • Becomes dysregulated within both the central nervous system (CNS) and gastrointestinal (GI) tract system when brain signaling is incorrectly messaged
  • Involves the hypothalamic-pituitary-adrenal axis as well as endogenous steroids, thyroid hormones, prostaglandins, melatonin, and peptides like leptin, cholecystokinin, peptide YY, and ghrelin.

Cellular oxidative stress (OS) 

In people and animals, healthy cells are in a state of oxidative balance. This occurs when sufficient cellular antioxidants (both small molecule scavengers and enzymes) avoid a buildup of excess free radicals or oxidizing agents. When oxidizing agents exceed antioxidants, a condition called OS develops. OS is known to trigger inflammatory responses and be an underlying cause of most chronic diseases. 

Chronic enteropathy (CE) is a prevalent intestinal inflammatory disorder in dogs, characterized by persistent and/or recurrent vomiting, diarrhea, decreased appetite, abdominal pain, and weight loss lasting longer than three weeks. 

Balancing microbiome and biomarker outcomes  

Balancing the microbiome restores it from dysbiosis to symbiosis to rebiosis. A balanced microbiome provides the following benefits: 

  • Promotes beneficial gut microbes
  • Improves protein digestion
  • Inhibits harmful bacteria
  • Tightens gut junctions via zonulin
  • Produces less intestinal gas and constipation.

 

Nuclear factor erythroid 2-related factor 2 (Nrf-2) activators in foods 

These compounds stimulate the Nrf-2 pathway and regulate the body’s antioxidant response to stress. Nrf-2 activation boosts production of endogenous antioxidants, protecting cells from oxidative damage. This helps reduce inflammation and pain, and mimics the cardiovascular benefits of exercise.  

This process is being investigated for benefits in a variety of disorders, including neurodegenerative diseases, diabetes, and cancer. Foods and supplements that reduce Nrf-2 include α-lipoic acid, berberine, cat’s claw, CoQ10, ginger, green tea, licorice, milk thistle, honey (not for the very young), resveratrol from blueberries and cranberries, soybeans, tomatoes (lycopene), turmeric (curcumin — without black pepper for pets) and vitamin E.  

Acute or chronic GI inflammation often leads to dysbiosis, which results in reduced microbial diversity as compared to healthy animals. Dysbiosis produces broad changes in microbial communities, decreased species diversity, alterations in the abundance of specific organisms, and thereby shifts in metabolite production. Importantly, healthy people and animals also may harbor unstable microbiota. Stabilizing the intestinal microbiota with diet, prebiotics, probiotics, symbiotics, and antimicrobials is important in controlling dysbiosis. These treatments may not be effective, however, and administration of antimicrobials may even increase antimicrobial resistance and dysbiosis.  

Symptoms of IBD in dogs 

A variety of symptoms can be observed in dogs with inflammatory bowel disease, including: 

  • Constipation 
  • Increased appetite, or loss of appetite (anorexia) 
  • Weight loss from poor digestion  
  • Dehydration 
  • Fatigue and sluggishness 
  • Paleness of gums and other mucous membranes 
  • Mild to severe abdominal pain (may become worse after eating) 
  • Depression 
  • Fever 
  • Increased heart rate. 

The effects of age on the GI tract 

Recent estimates indicate that 20% to 40% of dogs are over 11 years of age. Age-related GI tract changes are seen in humans, so parallel findings are likely to apply to pets. For example, a reduced output of pancreatic enzymes occurs, along with delayed gastric emptying, decreased enteric transport, and loss of lean body mass that reduces basal metabolic rate and energy needs. Reduced colonic motility contributes to chronic constipation. 

Affected dogs often have large volumes of pale, fatty feces, termed steatorrhea, although nutrient processing is usually unaffected as they age. Young affected dogs have chronic diarrhea or very soft, bulky, fatty-looking feces, excessive appetites, occasional vomiting, and gradual weight loss over a period of months. The high level of fats in the stool may cause the hair coat around the anus and on the tail to appear and feel oily. 

Causes of IBD in dogs 

Possible causes include genetic predisposition and nutritional factors, such as certain chemicals and toxins. Obesity linked to a high fat and low carbohydrate diet is also a risk factor. 

Another predisposing cause of IBD in people and pets is leaky gut syndrome. Triggers that cause intestinal inflammation and damage to the gut lining include:  

  • Dietary proteins and allergens (glutens) 
  • Low hydrochloric acid and gut enzymes 
  • Iron deficiency anemia 
  • Antibiotics and other drugs 
  • Microbial infections (bacteria, viruses, fungi, parasites) and pathogens 
  • Changes in blood sugars 
  • Presence of antibodies 
  • Organ failure 
  • Sex hormonal cycle changes including pregnancy and menopause 
  • Toxins like Clostridium spp, Salmonella spp, and E.coli. E. coli strains from IBD patients regulate two pathological features of IBD, namely cytokine expression and epithelial barrier function 
  • Physical, physiological and emotional stress.  

Genetic predisposition to IBD 

The latest research reveals a definitive connection between the gut microbiome, which helps food digestion, creates essential vitamins and minerals, and trains the immune system, and the heritability of IBD. For example, IBD occurs more commonly in German Shepherds, Soft-coated Wheaten Terriers, Boxers, Basenjis, Norwegian Lundehunds, French Bulldogs, Rottweilers, Irish Setters, and Shar-peis, all of which are genetically more susceptible due to immune system issues, as well as dietary and environmental factors. Some breeds even have specific forms of the condition.  

Diagnosing IBD in a dog 

Upon presentation to a veterinarian, a complete physical examination and series of lab tests should be performed to check for pancreatitis, diabetes, acid reflux, and even gallstones. X-rays and/or abdominal ultrasound imaging will likely be used to look for evidence of any injury to the pancreas. Inflammation can cause the pancreatic insulin-producing cells to be damaged, which could lead to diabetes.   

Specific laboratory tests for IBD 

  1. Complete blood count (CBC): Checks for anemia (low red blood cells/hemoglobin) from bleeding or high white blood cells from inflammation/infection. 
  1. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR): These are general inflammation markers; elevated levels suggest inflammation in the body, but aren’t specific to the gut. 
  1. Liver function tests: Can check for liver/bile duct issues sometimes linked to IBD. 
  1. Nutrient levels: Tests for iron, vitamins B12 and D, calcium and zinc, as IBD can affect absorption.  

Treating IBD in dogs 

It is important to restrict the dog’s activity level following treatment to allow for organ and tissue healing. Food and fluids will usually be stopped for a few days to give the gut and pancreas time to rest, and to slow the production of digestive enzymes. Fluid therapy may be needed during this time to prevent dehydration.  

Treatment is usually required for the rest of the pet’s life. If elevated folate levels are present, indicating small intestinal bacterial overgrowth (SIBO), a tylosin antibiotic (e.g. Tylan®) is often used. Iron supplementation, often given along with cobalamin (vitamin B12), is used for alleviating iron deficiency anemia.  

Drugs are used if vomiting occurs and persists. Pain relief may be needed as well. Antibiotics are used to help prevent infection, and surgery may be necessary to relieve any blockages and remove severely damaged tissues.   

The importance of phage use and therapy 

Bacteriophages were first discovered in 1917. They are living viruses that devour bacteria, and are ubiquitous, being found in water, soil, plants, and the human and animal body. The use of bacteriophages for human and animal bacterial infections was proposed by Felix d’Herelle at the beginning of the 20th century. While phage therapy was widely practiced in the Soviet Union in the 1930s and 1940s to treat a wide range of bacterial infections in dermatology, ophthalmology, urology, stomatology, pediatrics, otolaryngology, and surgery, it was not well known or received in Western medicine. However, due to the emergence of drug-resistant bacteria, renewed interest in phages arose for prophylaxis and therapy in the US, Europe, India and Asia.  ​ 

  • Phages kill only specific bacteria while leaving helpful bacteria and human cells unharmed.​​ 
  • Notably, phages can kill antibiotic-resistant bacteria. 
  • Phages targeting bacterial pests have been developed to protect crops and livestock.​ 
  • Numerous phage clinical trials are ongoing in the US, France, Switzerland, Belgium, the UK, and Australia. 
  • The FDA, USDA, and Agriculture Canada have approved phage products for food decontamination but not yet for other medical uses.​​ 

Alternative therapies for IBD 

Dietary modifications: Implement a hydrolyzed novel protein, or insect- and seaweed-based diet to reduce allergic reactions and inflammation. 

Probiotics: Introduce probiotics to help restore healthy gut flora and improve digestion. Look for strains like Lactobacillus, Bifidobacterium and Clostridium butyricum. 

Prebiotics: Incorporate prebiotics such as inulin or fructo-oligosaccharides to nourish beneficial bacteria. 

Omega-3 fatty acids: Use Omega-3 supplements to reduce inflammation and improve overall gut health. 

Herbal remedies: Explore natural anti-inflammatory herbs like slippery elm bark powder or marshmallow root for gastrointestinal support. Artichoke leaf extract reduces symptoms of irritable bowel syndrome and improves quality of life in otherwise healthy individuals suffering from concomitant dyspepsia. 

Iron and vitamin B12: Introduce supplementation as needed. 

Nutritional management  

Aging dogs that are overweight require more protein to support lean body mass and immune function, and fewer caloric nutrient-dense foods. In contrast, underweight dogs or those with co-morbidities that cause weight loss need increased caloric density. Managing nutritional intake plays an important role in controlling and treating IBD in dogs by supporting digestion and overall health. After episodes when food can safely be resumed, a bland, low fat, high carbohydrate, easily digestible diet is recommended. 

Foods that can be easily digested 

In dogs and people alike, some foods are more easily digested than others, particularly if the GI tract is inflamed. Fiber and fat can be more difficult for dogs with IBD to digest. On the other hand, foods high in moisture (canned foods) may be easier to digest. 

  • Dietary cellulose has the potential to accelerate stool consistency improvements. Mild changes in pathobionts, such as an increased level of Clostridium perfringens, are self-limiting; thus, antibiotic intervention is not warranted.
  • Dietary fiber includes an assortment of nondigestible carbohydrates that play a vital role in the health and maintenance of GI tract homeostasis. They physically alter the digesta, modulate appetite and satiety, regulate digestion, and act as a microbial energy source through fermentation. Examples include beet pulp and fruit-fiber supplements. 

Diet with minimal additives  

Feeding dogs a diet with limited additives and simple ingredients may help reduce IBD symptoms. Additives have been found to cause an immune reaction in some dogs, so they should be avoided wherever possible. 

Novel proteins 

Try new or never-before-used foods not known to be reactive to a particular patient: 

  • Insect-based diets. Consumer acceptance of these foods for dogs is multi-faceted and includes social, cultural, and ethical factors. Food preferences invoke issues around health and the environment, attitudes around the use of insects, and perceptions of benefits and risks.  

  • Seaweed-based diets. Edible seaweed has been part of Asian diets for thousands of years. It is a superfood, significantly higher in calcium, folate, iron, vitamin B complex, vitamin E, and zinc than broccoli. Seaweed also contains potassium, iodine, vitamins A, C and K, and minerals such as chromium, magnesium, selenium, manganese, bromine, and boron. Seaweed offers many health benefits: 
  • Detoxifying 
  • Antioxidant 
  • Anti-inflammatory 
  • Antimicrobial 
  • Provides healing benefits for diabetes, cancer (especially breast cancer), radiation poisoning, and obesity 
  • Prevents dental cavities 
  • Benefits cardiovascular and digestive health 
  • Helps keep skin and hair healthy 
  • Helps maintain electrolyte balance 
  • Reduces bloating from edema, as a natural diuretic  
  • Enhances libido 
  • Improves energy levels. 

Other foods that relieve IBD 

Additional foods that can aid digestion, prevent constipation, and block diarrhea include avocados, bananas, beans, blackberries, broccoli, Brussels sprouts, cabbage, cantaloupe, carrots, figs, flax, grapefruit, kale, mangoes, mushrooms, oats, peaches, peanuts, pomegranates, psyllium husk, pineapple, prunes, raspberries, rosemary, watermelon, and yogurt. 

Fecal microbiota transplantation (FMT)   

FMT involves the transfer of feces from a healthy donor to a diseased recipient. It’s aimed at directly modifying the recipient’s gut microbial ecosystem to restore the microbiota and its health benefits to the recipient. While the effects of this alternative method have not yet been clarified, it does contribute to enriching the microbiome and altering microbial profiles. 

A repeated FMT protocol can provide effective adjunct treatment in refractory CE dogs, especially those with no or mild dysbiosis. Marked dysbiosis and dysmetabolism of bile acids before and after FMT potentially require repeated procedures.  

FMT is a safe, well-tolerated, minimally invasive procedure that can be performed in any veterinary practice type. Establishing a fecal donor program is feasible for veterinarians, and donor screening guidelines can be modified on a case-by-case basis. 

Fresh feces should be utilized for FMT whenever possible. Specific recommendations for FMT product processing and preparation can be tailored to meet the availability of personnel and equipment resources for each practice. 

In veterinary medicine, the Companion Animal FMT Consortium currently recommends FMT as an adjunctive microbial-directed therapeutic for canine parvovirus enteritis, canine acute diarrhea, and chronic enteropathy in both dogs and cats 

In summary, managing canine IBD requires a multifaceted, individualized approach that addresses immune dysfunction, microbiome imbalance, and nutritional status. By integrating conventional therapies with targeted dietary strategies, microbiome support, and emerging modalities, you can move beyond symptom control toward improving gut integrity and long term health. 

References 

Adaptive Phage Therapeutics. www.aphage.com (accessed December 3, 2025). 

Atherly T, Rossi G, White R, Seo Y-J, Wang C, Ackermann M, Breuer M, Allenspach K, Mochel JP, Jergens AE. “Glucocorticoid and dietary effects on mucosal microbiota in canine inflammatory bowel disease”. PLoS One 2019;14:e0226780.  doi.org/10.1371/journal.pone.0226780. 

Barko PA, McMichael MA, Swanson KS, Williams DA. “The gastrointestinal microbiome: a review”. J Vet Intern Med, 2018;32:9–25. doi: 10.1111/jvim.14875. 

Benvenuti E, Pierini A, Gori E, Lucarelli C, Lubas G, Marchetti V. “Neutrophil-to-lymphocyte ratio (NLR) in canine inflammatory bowel disease (IBD)”. Vet Sci, 2020,7(3):141.  

doi: 10.3390/vetsci7030141. 

Bundy R, Walker AF, Middleton RW, Marakis G, Booth JC. “Artichoke leaf extract reduces symptoms of irritable bowel syndrome and improves quality of life in otherwise healthy volunteers suffering from concomitant dyspepsia: a subset analysis”. J Altern Complement Med, 2004 Aug;10 (4):667-669. doi: 10.1089/acm.2004.10.667. 

Carapeto S, Cunha E, Serrano I, Pascoal P, Pereira M, Abreu R, Neto S, Antunes B, Dias R, Tavares L, Oliveira M. “Effect of the administration of a lyophilised faecal capsules on the intestinal microbiome of dogs: a pilot study”. Genes 2023, 14: 1676. doi.org/10.3390/genes14091676. 

Chanishvili N. “Phage therapy-history from Twort and d’Herelle through Soviet experience to current approaches”. Adv Virus Res, 2012; 83:3–40. doi.org/10.1016/B978-0-12-394438-2.00001-3. 

Craven MD, Washabau RJ. “Comparative pathophysiology and management of protein-losing enteropathy”. J Vet Intern Med, 2019;33:383–402. doi: 10.1111/jvim.15406. 

Di Candido F. “Quality of life in inflammatory bowel disease (IBDs) patients after surgery”. Rev Recent Clin Trials 2022;17: 227–239. doi: 10.2174/1574887117666220811143426. 

Dodds WJ. “ Salivary diagnostics direct diet therapy”. AHVMA Webinar, October 3, 2021. 

Dodds WJ. “Nutrition and the microbiome”. Irish Wolfhound Health Group Webinar, London, UK. April 24, 2022. doi.org/10.1099/00221287-133-5-1111. 

Duffner T. “Pet iron deficiency linked to gut disease. The underlying issue stealing your pet’s strength”. Bark & Whiskers (Accessed Jan 31, 2026). 

Elliott TR, Hudspith BN, Wu G, Cooley M, Parkes G, Quiñones B, Randall L, Mandrell RE, Fagerquist CK, Brostoff J, Rayment NB, Boussioutas A, Petrovska L, Sanderson JD.  

“Quantification and characterization of mucosa-associated and intracellular Escherichia coli in inflammatory bowel disease”. Inflammatory Bowel Diseases, 2013, 19(11), 2326-2338.   

doi.org/10.1097/MIB.0b013e3182a38a92. 

Farré R, Fiorani M, Rahiman SA, Matteoli G. “Intestinal permeability, inflammation and the role of nutrients”. Nutrients 2020, 12: 1185. doi:10.3390/nu12041185. 

Fernández-Pinteño A, Pilla R, Suchodolski J, Apper E, Torre C, Salas-Mani A, Manteca X. “Age-related changes in gut health and behavioral biomarkers in a Beagle dog population”. Animals 2025, 15: 234. doi.org/10.3390/ani15020234. 

Gaylord LB. “Nutritional management for aging dogs and cats – evidence-based strategies”. Vet Pract News 37(11), November 2025:30-31. 

Green J, Kathrani A. “Incidence of relapse of inflammatory protein-losing enteropathy in dogs and associated risk factors”. J Vet Intern Med, 2022;36:1981–1988. doi: 10.1111/jvim.16561. 

Grieneisen L, Dasari M, Gould TJ, Björk JR, Grenier J-C, Yotova V, et al. “Gut microbiome heritability is nearly universal but environmentally contingent”. Science 2021, 373(6551):181-186. doi:10.1126/science.aba5483. 

Hagmeyer R. “Leaky gut syndrome”. (Accessed July 7, 2025) www. drhagmeyer.com/leaky-gut/ 

Ha J-H, Jeong Y, Kwak H-H, Choi S, Ahn J-O, Chung J-Y. “Prognosis for surgical intestinal resection in inflammatory bowel disease refractory to medical treatment in a dog”. Can Vet J, 2025; 66(12):1303-1307.  

Holz M, Fritz J, Suchodolski JS, Werner M, Unterer S. “Effects of dietary cellulose on clinical and gut microbiota recovery in dogs with uncomplicated acute diarrhea: a randomized prospective clinical trial”. JAVMA, 263(2):169. doi.org/10.2460/javma.24.07.0476. 

Hunt A, Jugan MC. “Anemia, iron deficiency, and cobalamin deficiency in cats with chronic intestinal disease”. J Vet Int Med, 2021;35:172-178. doi.org/10/1111/jvim.15982. 

Jergens AE, Simpson KW. “Inflammatory bowel disease in veterinary medicine”. Front Biosci, 2012;4:1404–1419. doi: 10.2741/e470. 

Le Bon M, Carvell-Miller L, Marshall-Jones Z, Watson P, Amos G. “A novel prebiotic fibre blend supports the gastrointestinal health of senior dogs”. Animals 2023, 13: 3291. doi.org/10.3390/ani13203291. 

Lowenfeld L, Cologne KG. “Postoperative considerations in inflammatory bowel disease”. Surg Clin 2019; 99:1095–1109. doi: 10.1016/j.suc.2019.08.003. 

Marchetti V, Lubas G, Lombardo A, Corazza M, Guidi G, Cardini G. “Evaluation of erythrocytes, platelets, and serum iron profile in dogs with chronic enteropathy”. Vet Med Int, 2010, 716040. 

Marchesi MC, Maggi G, Cremonini V, Miglio A, Contiero B, Guglielmini C, Antognoni MT. “Monocyte count, NLR, MLR, PLR in canine inflammatory bowel disease”. Animals 2024, 14(6):837. doi: 10.3390/ani14060837. 

McCown JL, Specht AJ. “Iron homeostasis and disorders in dogs and cats: A review”. J Am Anim Hosp Assoc, 2011, 47, 151–160. 

Melotto KSK, Souza RBMS, Fernandes EL, Santos LNA, Lima LS, Silva HL, Oliveira SG, Félix AP. “Metronidazole-sulfadimethoxine c.ombination affects diet digestibility, immunity indicators, fermentation metabolites, and intestinal microbiome of puppies”. JAVMA, 263(10):1259. doi.org/10.2460/javma.25.02.0109. 

Merril CR, Biswas B, Carlton R, et al. “Long-circulating bacteriophage as antibacterial agents”. Proc Natl Acad Sci USA, 1996; 93:3188–92. doi.org/10.1073/pnas.93.8.3188. 

Montserrat-Malagarriga M, Castillejos L, Salas-Mani A, Torre C, Martín-Orúe SM. “The impact of fiber source on digestive function, fecal microbiota, and immune response in adult dogs”. Animals 2024, 14: 196. doi.org/10.3390/ani14020196. 

Moreno AA, Parker VJ, Winston JA, Rudinsky AJ. “Dietary fiber aids in the management of canine and feline gastrointestinal disease”. JAVMA,260 (S3): S33.    doi.org/10.2460/javma.22.08.0351. 

Nicotra M, Iannitti T, Di Cerbo A. “Nutraceuticals, social interaction, and psychophysiological influence on pet health and well-being: focus on dogs and cats”. Vet Sci, 2025, 12: 964. doi.org/10.3390/vetsci12100964. 

Niina A, Kibe R, Suzuki R, Yuchi Y, Teshima T, Matsumoto H, Kataoka Y, Koyama H. “Fecal microbiota transplantation as a new treatment for canine inflammatory bowel disease”. Bioscience of Microbiota, Food and Health, 2021, 40 (2): 98-104. 

Phages for Global Health. www.phagesforglobalhealth.org. 

Pinney J, Costa-Font M. “A model for consumer acceptance of insect-based dog foods among adult UK dog owners”. Animals 2024, 14: 1021. doi.org/10.3390/ani14071021. 

Reveles K, Meehan Joni, Tillotson G. (2025). “Fecal microbiota transplantation in animals: therapeutics, conservation, and farming”. Microorganisms. 13: 2465. doi:10.3390/microorganisms13112465. 

Ristic JM, Stidworthy MF. “Two cases of severe iron-deficiency anaemia due to inflammatory bowel disease in the dog”. J Small Anim Pract, 2002, 43 (2): 80-83. doi: 10.1111/j.1748-5827.2002.tb00034.x. 

Rojas CA, Entrolezo Z, Jarett JK, Jospin G, Martin A, Ganz HH. “Microbiome responses to oral fecal microbiota transplantation in a cohort of domestic dogs”. Vet Sci, 2024, 11: 42. doi.org/10.3390/vetsci11010042. 

Roman M. “The gut microbiome and its effect on behavior in dogs and cats”. Inn Vet Care J, 2024; April 26. 

Sanchez-Castro C, Loor-Giler A, Santander-Parra S, Campos M, Mena-Pérez R, Prado-Chiriboga S, Nuñez L. “First molecular insights into the presence of Canine Kobuvirus in Ecuadorian dogs through the standardization of a sensitive SYBR green RT-qPCR assay”. Vet Sci, 2025, 12, 1076. doi.org/10.3390/vetsci12111076. 

Sasaki M, Sitaraman SV, Babbin BA, Gerner-Smidt P, Ribot EM, Garrett N, Alpern JA, Akyildiz A, Theiss AL, Nusrat A, Klapproth JM Sitaraman SV, Babbin BA, Gerner-Smidt P, Ribot EM, Garrett N, Alpern JA, Akyildiz A, Theiss AL, Nusrat A, Klapproth JM. “Invasive Escherichia coli as a feature of Crohn’s disease”. Lab Invest, 2007. 87 (10):1042-1052. www.nature.com/artcles/3700661. 

Simpson KW, Dogan B, Rishniw M, Goldstein RE, Suzanne Klaessig S, et al. “Adherent and invasive Escherichia coli is associated with granulomatous colitis in Boxer dogs”. Infect & Immun, Aug. 2006: 4778–4792. doi:10.1128/IAI.00067-06. 

Smith B. “The heroes within-utilizing the gut microbiome, microbiome therapeutics, and fecal microbiota transplant in managing companion animal health and disease”. JAVMA, 263 (S2):S45. doi.org/10.2460/javma.25.03.0218. 

Smith HW, Huggins MB, Shaw KM. “The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages”. J Gen Microbiol, 1987; 133(5):1111–1126.    

Tolbert M, Murphy M, Gaylord L, Witzel-Rollins A. “Dietary management of chronic enteropathy in dogs”. J Small Anim Pract, 2022;63:425–434. doi: 10.1111/jsap.13471. 

Toresson L, Ludvigsson U, Olmedal G, Hellgren J, Toni M, Giaretta PR, Blake AB, PhD, Suchodolski JS. “Repeated fecal microbiota transplantation in dogs with chronic enteropathy can decrease disease activity and corticosteroid usage”. JAVMA, 263, Nov 2025. doi.org/10.2460/javma.25.08.0563. 

Wentz I. “The root cause of inflammatory bowel disease”. (Accessed Jan 23, 2026). 

Winston JA, Suchodolski JS, Gashen F, Verocai GG, Werner M, Ziese A-L. “Clinical guidelines for fecal microbiota transplantation in companion animals”. Adv Small An Care 2024, 5(1): 79–107. 

Zeldovich L. “Living Medicine: How a lifesaving cure was nearly lost – and why it will rescue us when antibiotics fail”. St. Martin’s Press, New York, NY, October 2024; 320 pp. 

 

 

Figure 1: Cytokine storm images (adapted from AltaSciences, Montreal QC, 2025, www.altasciences.com) 

 

 

 

 

 

 

Figure 2: From left to right: dogs with a) intestinal gas, b) scratching and burping, and c) intestinal cramping (www.nutriscanlabs.org) 

 

 

                 Fig. 2a                                Fig. 2b                                           Fig.2c 

AUTHOR PROFILE

Innovative Veterinary Care Journal bridges the gap between the worlds of allopathic and integrative veterinary care. Thousands of veterinarians and vet technicians are interested in ways to enhance their practice and update their skills…and integrative health is considered to be highly innovative and requested by patients along with a vast number of other traditional and emerging techniques. IVC features articles by some of the top experts, focusing on market trends in health treatments, new product features, industry news, how to create a strong retail experience, leading integrative modalities, and nutrition education not typically taught in vet school.

RELATED ARTICLESMORE FROM AUTHOR